There were 1,937 press releases posted in the last 24 hours and 434,311 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image